Archive: Cardinal Health Specialty Services Asks Therigy to Analyze Critical Events in Biopharmaceutical Pipeline

Cardinal Health, a leader in products and services that help improve quality, safety, and efficiency all along the chain of care, looks to Therigy to analyze and report key developments in the specialty drug pipeline. Therigy's expertise in evaluation and interpretation of drugs making their way through clinical trials brings Cardinal value well beyond simple tracking and monitoring obtained readily through a variety of other sources in the industry. Therigy provides benchmarks and comparisons within disease states, along with recommendations for drug access across pharmacy and wholesale distribution channels. These insights keep Cardinal well ahead of the changes resulting from new drugs.

"We are very pleased to provide Cardinal Health with insights to the robust pipeline of specialty pharmaceuticals," says Russel Allinson, RPh, MS, CEO and co-founder of Therigy.